Published in Int J Radiat Oncol Biol Phys on February 02, 2006
Comparison of dose distributions and organs at risk (OAR) doses in conventional tangential technique (CTT) and IMRT plans with different numbers of beam in left-sided breast cancer. Rep Pract Oncol Radiother (2011) 1.08
Effect of breathing motion in radiotherapy of breast cancer: 4D dose calculation and motion tracking via EPID. Strahlenther Onkol (2009) 0.96
Dosimetric evaluation of whole breast radiotherapy using field-in-field technique in early-stage breast cancer. Int J Clin Oncol (2011) 0.91
Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview. Radiat Oncol (2006) 0.85
Measurement of mean cardiac dose for various breast irradiation techniques and corresponding risk of major cardiovascular event. Front Oncol (2014) 0.83
Doses to internal organs for various breast radiation techniques--implications on the risk of secondary cancers and cardiomyopathy. Radiat Oncol (2011) 0.83
Optimizing of the tangential technique and supraclavicular fields in 3 dimensional conformal radiation therapy for breast cancer. J Med Signals Sens (2013) 0.82
DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90
A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol (2008) 5.26
Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med (2010) 4.63
The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer (2005) 2.69
Increased risk of type 2 diabetes in Alzheimer disease. Diabetes (2004) 2.61
Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst (2003) 2.51
Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol (2005) 2.20
A permanent breast seed implant as partial breast radiation therapy for early-stage patients: a comparison of palladium-103 and iodine-125 isotopes based on radiation safety considerations. Int J Radiat Oncol Biol Phys (2005) 2.07
Cellular dosimetry of (111)In using monte carlo N-particle computer code: comparison with analytic methods and correlation with in vitro cytotoxicity. J Nucl Med (2010) 2.07
Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163. J Clin Oncol (2009) 2.04
A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat (2003) 1.98
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J Natl Compr Canc Netw (2006) 1.88
Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes (2009) 1.82
Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol (2004) 1.80
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev (2012) 1.79
Correlation of lung tumor motion with external surrogate indicators of respiration. Int J Radiat Oncol Biol Phys (2004) 1.62
Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy. J Clin Oncol (2007) 1.56
Stereoselective aziridination of cyclic allylic alcohols using chloramine-T. Org Biomol Chem (2008) 1.55
Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev (2005) 1.54
Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol (2005) 1.44
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells. Clin Cancer Res (2011) 1.35
The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study. BMC Cancer (2006) 1.30
The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Res Treat (2006) 1.30
A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. Int J Radiat Oncol Biol Phys (2010) 1.26
Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J (2008) 1.24
Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clin Ther (2007) 1.20
Asymmetric deprotonation of N-boc piperidine: react IR monitoring and mechanistic aspects. J Am Chem Soc (2010) 1.18
Surgery for osteitis pubis. Can J Surg (2006) 1.15
Prognostic and predictive molecular markers in DCIS: a review. Adv Anat Pathol (2005) 1.14
Keeping faith with trial volunteers. Nature (2007) 1.13
Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: comparison with manual counting. Int J Radiat Biol (2011) 1.09
Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat (2005) 1.08
Catalytic asymmetric deprotonation using a ligand exchange approach. J Am Chem Soc (2005) 1.07
Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study. Int J Radiat Oncol Biol Phys (2008) 1.03
Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res Treat (2012) 1.01
Impact of case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota. Am J Epidemiol (2002) 0.99
Adjuvant targeted therapy in early breast cancer. Cancer (2009) 0.99
A readily-accessible (+)-sparteine surrogate. J Am Chem Soc (2002) 0.99
Enantioselective, palladium-catalyzed α-arylation of N-Boc pyrrolidine: in situ react IR spectroscopic monitoring, scope, and synthetic applications. J Org Chem (2011) 0.98
Synthesis of the azaphilones (+)-sclerotiorin and (+)-8-O-methylsclerotiorinamine utilizing (+)-sparteine surrogates in copper-mediated oxidative dearomatization. J Org Chem (2011) 0.97
Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography. Transl Oncol (2013) 0.97
Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Breast Cancer Res Treat (2004) 0.96
Palladium-catalyzed enantioselective oxidation of chiral secondary alcohols: access to both enantiomeric series. Angew Chem Int Ed Engl (2008) 0.94
Evaluation of (+)-sparteine-like diamines for asymmetric synthesis. J Org Chem (2004) 0.94
Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skin. Int J Radiat Oncol Biol Phys (2008) 0.93
A new sparteine surrogate for asymmetric deprotonation of N-Boc pyrrolidine. Org Lett (2008) 0.93
Diamine-free lithiation-trapping of N-Boc heterocycles using s-BuLi in THF. Org Lett (2010) 0.93
Prediction of lung tumour position based on spirometry and on abdominal displacement: accuracy and reproducibility. Radiother Oncol (2006) 0.93
Endstage arthritis following tibia plateau fractures: average 10-year follow-up. Can J Surg (2012) 0.92
Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition. Med Phys (2010) 0.92
Inverse vs. forward breast IMRT planning. Med Dosim (2005) 0.91
First report of a permanent breast 103Pd seed implant as adjuvant radiation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys (2005) 0.90
Fatty acid metabolism in the elderly: effects of dehydroepiandrosterone and testosterone replacement in hormonally deficient men and women. J Clin Endocrinol Metab (2009) 0.90
Platinum-based chemotherapy in triple-negative advanced breast cancer. Breast Cancer Res Treat (2014) 0.90
Optimism and survival in lung carcinoma patients. Cancer (2004) 0.90
Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer. Int J Radiat Oncol Biol Phys (2005) 0.90
Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience. Int J Radiat Oncol Biol Phys (2013) 0.90
Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Mol Pharm (2012) 0.89
An experimental and in situ IR spectroscopic study of the lithiation-substitution of N-Boc-2-phenylpyrrolidine and -piperidine: controlling the formation of quaternary stereocenters. J Am Chem Soc (2012) 0.89
Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture. Oncotarget (2014) 0.89
Reactivity series for s-BuLi/diamine-mediated lithiation of N-Boc pyrrolidine: applications in catalysis and lithiation of N-Boc piperidine. Chem Commun (Camb) (2006) 0.88
On the two-ligand catalytic asymmetric deprotonation of N-boc pyrrolidine: probing the effect of the stoichiometric ligand. J Org Chem (2008) 0.86
Lithiation-electrophilic trapping of N-sulfonyl-activated ethylene aziridines. Org Biomol Chem (2008) 0.86
Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer. Mol Pharm (2010) 0.86
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2003) 0.85
Web based pathology assessment in RTOG 98-04. J Clin Pathol (2014) 0.84
Sub-picomole colorimetric single nucleotide polymorphism discrimination using oligonucleotide-nanoparticle conjugates. Analyst (2004) 0.84
Extended-working-distance multiphoton micromanipulation microscope for deep-penetration imaging in live mice and tissue. J Biomed Opt (2009) 0.83
Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ. Histopathology (2014) 0.83
Amines bearing tertiary substituents by tandem enantioselective carbolithiation-rearrangement of vinylureas. Org Lett (2012) 0.83
Experimental measurement of radiological penumbra associated with intermediate energy x-rays (1 MV) and small radiosurgery field sizes. Med Phys (2007) 0.83
Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small-cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys (2004) 0.82
Biological Markers Predictive of Invasive Recurrence in DCIS. Clin Med Oncol (2008) 0.82
Concise synthesis of (+/-)-cytisine via lithiation of N-Boc-bispidine. Org Lett (2005) 0.82
Organolithium-mediated conversion of beta-alkoxy aziridines into allylic sulfonamides: effect of the N-sulfonyl group and a formal synthesis of (+/-)-perhydrohistrionicotoxin. J Org Chem (2008) 0.81
Ductal carcinoma in situ of the breast: can biomarkers improve current management? Clin Chem (2013) 0.81
Influence of breast composition and interseed attenuation in dose calculations for post-implant assessment of permanent breast 103Pd seed implant. Phys Med Biol (2010) 0.81
Reductive alkylation of beta-alkoxy aziridines: new route to substituted allylic amines. Org Lett (2004) 0.81
Modeling xenobiotic susceptibility to hepatotoxicity using an in vitro oxidative stress inflammation model. Can J Physiol Pharmacol (2013) 0.81
Catalytic asymmetric synthesis of piperidines from pyrrolidine: concise synthesis of L-733,060. Org Lett (2009) 0.81
Signaling receptors on platelets and megakaryocytes. Methods Mol Biol (2004) 0.80
New route to azaspirocycles via the organolithium-mediated conversion of beta-alkoxy aziridines into cyclopentenyl amines. Org Lett (2006) 0.80
Fixation of marginal posterior acetabular wall fractures using locking reconstruction plates and monocortical screws. J Trauma (2010) 0.80
Full-thickness closure in breast-conserving surgery: the impact on radiotherapy target definition for boost and partial breast irradiation. A multimodality image evaluation. Ann Surg Oncol (2014) 0.80
Establishment of normative data for the amount of breast tissue present in healthy children up to two years of age. J Pediatr Adolesc Gynecol (2010) 0.80
Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitus. Contemp Clin Trials (2010) 0.79
Clinical significance of atomic inner shell ionization (ISI) and Auger cascade for radiosensitization using IUdR, BUdR, platinum salts, or gadolinium porphyrin compounds. Int J Radiat Oncol Biol Phys (2003) 0.79
A critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosis. Am J Pathol (2006) 0.79
Overlapping dislocation of the pubic symphysis: report of three cases and review of the literature. Arch Orthop Trauma Surg (2009) 0.79
Decisional support throughout the cancer journey for older women diagnosed with early stage breast cancer: a single institutional study. J Cancer Educ (2014) 0.78
Halogen-bonded liquid crystals of 4-alkoxystilbazoles with molecular iodine: a very short halogen bond and unusual mesophase stability. Chem Commun (Camb) (2013) 0.78
Synthesis of P-stereogenic phospholene boranes via asymmetric deprotonation and ring-closing metathesis. Org Lett (2012) 0.78
Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasis. Breast (2007) 0.78
Preparation and reactions of enantiomerically pure α-functionalized Grignard reagents. J Am Chem Soc (2013) 0.78